Cerebellum’s LivaNova LIVN Stock Holding History

Cerebellum’s Portfolio LIVN Stock Details LIVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,598	Closed	-$128K	–	497
2020 Q2	$128K	Buy	+1,598	New	+$80.1K	0.09%	170
2018 Q4	–	Sell	-1,544	Closed	-$191K	–	497
2018 Q3	$191K	Buy	+1,544	New	+$182K	0.3%	37
2018 Q2	–	Sell	-2,151	Closed	-$190K	–	475
2018 Q1	$190K	Buy	2,151 +553	+35%	+$47.1K	0.24%	113
2017 Q4	$128K	Buy	+1,598	New	+$127K	0.09%	170

Other funds holding LIVN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Cerebellum's LIVN Position: Q3 2020 in Review

Cerebellum sold out of LivaNova (LIVN) in Q3 2020, closing a stake of 1,598 shares — an estimated $128K sold.

Cerebellum first reported a position in LIVN in Q4 2017 and held it in 4 quarters. The position peaked at $191K in Q3 2018. 180 funds tracked by Wall St. Rank hold LIVN as of Q3 2020.

Cerebellum reported no remaining LivaNova position as of Q3 2020 after selling out during the quarter.
Cerebellum sold 1,598 LivaNova shares in Q3 2020, an estimated $128K.
Cerebellum first reported a position in LivaNova in Q4 2017 and held it in 4 quarters.
Cerebellum's LivaNova position peaked at $191K in Q3 2018.
180 funds tracked by Wall St. Rank held LivaNova as of Q3 2020.

Based on Cerebellum's 13F filing for Q3 2020, filed 21 Oct 2020.